|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu J, Xue H, Zhang J, Suo T, Xiang Y,
Zhang W, Ma J, Cai D and Gu X: MicroRNA-144 inhibits the metastasis
of gastric cancer by targeting MET expression. J Exp Clin Cancer
Res. 34:352015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang CS, Hsieh CC, Chao TC, Jan YY, Jeng
LB, Hwang TL, Chen MF, Chen PC, Chen JS and Hsueh S: Resectable
gastric cancer: Operative mortality and survival analysis. Chang
Gung Med J. 25:216–227. 2002.PubMed/NCBI
|
|
4
|
Ye YW, Dong RZ, Zhou Y, Du CY, Wang CM, Fu
H and Shi YQ: Prognostic analysis of familial gastric cancer in
Chinese population. J Surg Oncol. 104:76–82. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Meyer HJ and Wilke H: Treatment strategies
in gastric cancer. Dtsch Arztebl Int. 108:698–705. 2011.PubMed/NCBI
|
|
6
|
Kim SJ, Wang YG, Lee HW, Kang HG, La SH,
Choi IJ, Irimura T, Ro JY, Bresalier RS and Chun KH: Up-regulation
of neogenin-1 increases cell proliferation and motility in gastric
cancer. Oncotarget. 5:3386–3398. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Otani K, Li X, Arakawa T, Chan FK and Yu
J: Epigenetic-mediated tumor suppressor genes as diagnostic or
prognostic biomarkers in gastric cancer. Expert Rev Mol Diagn.
13:445–455. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hutvágner G and Zamore PD: A microRNA in a
multiple-turnover RNAi enzyme complex. Science. 297:2056–2060.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cortés-Sempere M and de Ibáñez Cáceres I:
microRNAs as novel epigenetic biomarkers for human cancer. Clin
Transl Oncol. 13:357–362. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Croce CM and Calin GA: miRNAs, cancer, and
stem cell division. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death and tumorigenesis. Br J Cancer.
96:(Suppl). R40–R44. 2007.PubMed/NCBI
|
|
12
|
Gregory RI and Shiekhattar R: MicroRNA
biogenesis and cancer. Cancer Res. 65:3509–3512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stenvang J, Petri A, Lindow M, Obad S and
Kauppinen S: Inhibition of microRNA function by antimiR
oligonucleotides. Silence. 3:12012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bou Kheir T, Futoma-Kazmierczak E,
Jacobsen A, Krogh A, Bardram L, Hother C, Grønbæk K, Federspiel B,
Lund AH and Friis-Hansen L: miR-449 inhibits cell proliferation and
is down-regulated in gastric cancer. Mol Cancer. 10:292011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ma G, Dai W, Sang A, Yang X and Gao C:
Upregulation of microRNA-23a/b promotes tumor progression and
confers poor prognosis in patients with gastric cancer. Int J Clin
Exp Pathol. 7:8833–8840. 2014.PubMed/NCBI
|
|
19
|
Chang L, Guo F, Huo B, Lv Y, Wang Y and
Liu W: Expression and clinical significance of the microRNA-200
family in gastric cancer. Oncol Lett. 9:2317–2324. 2015.PubMed/NCBI
|
|
20
|
Qiu T, Zhou X, Wang J, Du Y, Xu J, Huang
Z, Zhu W, Shu Y and Liu P: MiR-145, miR-133a and miR-133b inhibit
proliferation, migration, invasion and cell cycle progression via
targeting transcription factor Sp1 in gastric cancer. FEBS Lett.
588:1168–1177. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin X, Yang Z, Zhang P and Shao G: miR-154
suppresses non-small cell lung cancer growth in vitro and in vivo.
Oncol Rep. 33:3053–3060. 2015.PubMed/NCBI
|
|
22
|
Kai Y, Qiang C, Xinxin P, Miaomiao Z and
Kuailu L: Decreased miR-154 expression and its clinical
significance in human colorectal cancer. World J Surg Oncol.
13:1952015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xin C, Zhang H and Liu Z: miR-154
suppresses colorectal cancer cell growth and motility by targeting
TLR2. Mol Cell Biochem. 387:271–277. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu C, Shao P, Bao M, Li P, Zhou H, Cai H,
Cao Q, Tao L, Meng X, Ju X, et al: miR-154 inhibits prostate cancer
cell proliferation by targeting CCND2. Urol Oncol. 32(31): e9–e16.
2014.
|
|
25
|
Zhu C, Li J, Cheng G, Zhou H, Tao L, Cai
H, Li P, Cao Q, Ju X, Meng X, et al: miR-154 inhibits EMT by
targeting HMGA2 in prostate cancer cells. Mol Cell Biochem.
379:69–75. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu X, Wang S, Yuan A, Yuan X and Liu B:
MicroRNA-140 represses glioma growth and metastasis by directly
targeting ADAM9. Oncol Rep. 36:2329–2338. 2016.PubMed/NCBI
|
|
27
|
Shi C and Zhang Z: MicroRNA-362 is
downregulated in cervical cancer and inhibits cell proliferation,
migration and invasion by directly targeting SIX1. Oncol Rep.
37:501–509. 2017.PubMed/NCBI
|
|
28
|
Wang LL, Wang L, Wang XY, Shang D, Yin SJ,
Sun LL and Ji HB: MicroRNA-218 inhibits the proliferation,
migration, and invasion and promotes apoptosis of gastric cancer
cells by targeting LASP1. Tumour Biol. 37:15241–15252. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim DH, Mohapatra G, Bollen A, Waldman FM
and Feuerstein BG: Chromosomal abnormalities in glioblastoma
multiforme tumors and glioma cell lines detected by comparative
genomic hybridization. Int J Cancer. 60:812–819. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Poon TC, Wong N, Lai PB, Rattray M,
Johnson PJ and Sung JJ: A tumor progression model for
hepatocellular carcinoma: Bioinformatic analysis of genomic data.
Gastroenterology. 131:1262–1270. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gnosa S, Shen YM, Wang CJ, Zhang H,
Stratmann J, Arbman G and Sun XF: Expression of AEG-1 mRNA and
protein in colorectal cancer patients and colon cancer cell lines.
J Transl Med. 10:1092012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang Y, Klijn JG, Zhang Y, Sieuwerts AM,
Look MP, Yang F, Talantov D, Timmermans M, Meijer-van Gelder ME, Yu
J, et al: Gene-expression profiles to predict distant metastasis of
lymph-node-negative primary breast cancer. Lancet. 365:671–679.
2005. View Article : Google Scholar
|
|
33
|
Hu G, Wei Y and Kang Y: The multifaceted
role of MTDH/AEG-1 in cancer progression. Clin Cancer Res.
15:5615–5620. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sarkar D, Emdad L, Lee SG, Yoo BK, Su ZZ
and Fisher PB: Astrocyte elevated gene-1: Far more than just a gene
regulated in astrocytes. Cancer Res. 69:8529–8535. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Baygi ME and Nikpour P: Deregulation of
MTDH gene expression in gastric cancer. Asian Pac J Cancer Prev.
13:2833–2836. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dong L, Qin S, Li Y, Zhao L, Dong S, Wang
Y, Zhang C and Han S: High expression of astrocyte elevated gene-1
is associated with clinical staging, metastasis, and unfavorable
prognosis in gastric carcinoma. Tumour Biol. 36:2169–2178. 2015.
View Article : Google Scholar : PubMed/NCBI
|
